GlaxoSmithKline S.A./NV

Banks, commodities put pressure on European stocks.
Financial Mirror (Cyprus); 12/7/2009; 805 words; ...after data showed U.S. employers cut far fewer...the economy, but it's not so great for the stock...drugmakers. AstraZeneca, GlaxoSmithKline, Merck, Novo Nordisk...Across Europe, Britain's FTSE 100 index, Germany...ore market. Heineken NV, the world's third...

Fragment-Based Platform Lands Another Early Stage Astex Deal.
BioWorld International; 11/18/2009; 1115 words; ...Managing Editor Last year's crumbling markets might...based discovery deal with GlaxoSmithKline plc. The London-based...it to market, Astex's end of the deal could...Janssen Pharmaceutica NV, a unit of New Brunswick...for access to the firm's technology. The Pyramid...

Low-Flying Calmune Emerges in Antibody Deal with Crucell.
BIOWORLD Today; 11/4/2009; 1036 words; ...the Netherlands-based Crucell NV. It centers on Calmune's SEBVI technology platform, which...a natural fit" for Calmune's first deal, Williamson told...Domantis Ltd. was snatched up by GlaxoSmithKline plc. Most recently, Princeton...

GSK Spin-Off Affymax Generates $20M In Private Financing Round.
BIOWORLD Today; 11/4/2009; 1116 words; ...Hematide, the company's pipeline has grown...its spin-off from GlaxoSmithKline plc nearly two years ago. Affymax's investors purchased...in 1988 as Affymax NV, the company subsequently...part of Affymax's subsidiary, Santa...passive investor, GlaxoSmithKline's shares have ...

Other News To Note.
BIOWORLD Today; 11/4/2009; 1607 words; ...not disclosed. Crucell NV, of Leiden, the Netherlands...further develop GenVec's lead cardiovascular product...milestone payment from GlaxoSmithKline plc, of London. The...investigate at two U.S. centers the safety...not guilty Monday in U.S. District Court in Manhattan...